Skip to main navigation
Skip to search
Skip to main content
Research Explorer The University of Manchester Home
Search content at Research Explorer The University of Manchester
Home
Profiles
Research units
Research output
Projects
Impacts
Activities
Press/Media
Prizes
Equipment
Datasets
Student theses
BRAF as therapeutic target in melanoma
Claudia Wellbrock
,
Adam Hurlstone
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'BRAF as therapeutic target in melanoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
100%
Mitogen Activated Protein Kinase
60%
Phosphotransferase
40%
Sorafenib
40%
Phase I Trials
20%
Malignant Neoplasm
20%
Neoplasm
20%
Epidermal Growth Factor Receptor
20%
Cutaneous Melanoma
20%
B Raf Kinase
20%
Vemurafenib
20%